经导管主动脉瓣置换术后合并心房颤动的抗栓策略  

Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation

作　　者：李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄 LI Zongze;HE Guijun;ZHENG Xiaofei;JIANG Hui;LIU Hanxiong(Department of Cardiology,Pengzhou Traditional Chinese Medicine Hospital,Pengzhoo 611930,Sichuan,China;Department of Cardiology,The Third People’s Hospital of Chengdu,The Affiliated Hospital of Southwest Jiaotong University,Chengdu 610031,Sichuan,China)

机构地区：[1]彭州市中医医院心血管内科,四川彭州611930 [2]西南交通大学附属医院成都市第三人民医院心血管内科,四川成都610031

出　　处：《心血管病学进展》2021年第10期892-896,共5页Advances in Cardiovascular Diseases

基　　金：四川省科技计划项目(应用基础研究)(2020YJ0483)。

摘　　要：主动脉瓣狭窄是一类常见的心瓣膜病,近年来由于经导管主动脉瓣置换术的研究和应用,主动脉瓣狭窄重新受到关注。经导管主动脉瓣置换术后患者常合并心房颤动,心房颤动增加了经导管主动脉瓣置换术后患者心血管死亡或卒中致残的风险。目前尚不清楚经导管主动脉瓣置换术后心房颤动患者的最佳抗栓策略,现就相关研究做一综述。Aortic stenosis(AS)is a common class of valvular heart disease,and AS has received renewed attention in recent years due to the research and application of transcatheter aortic valve replacement(TAVR).Atrial fibrillation(Af)is prevalent in patients with AS undergoing TAVR,which increased the risk of cardiovascular death or disabling stroke.With the application of TAVR increases,However,the optimal antithrombotic regimen of Af after TAVR remains unknown.In this review,we briefly introduce the management strategies of antithrombotic therapy related studies to explore the optimal antithrombotic management for patients with Af after TAVR.

关 键 词：经导管主动脉瓣置换术 抗栓治疗 主动脉瓣狭窄 心房颤动 

分 类 号：R654.2[医药卫生—外科学] R541.75[医药卫生—临床医学]